Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis
NCT ID: NCT03151018
Last Updated: 2017-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2015-05-31
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To establish a prospective registry of the whole patients who received percutaneous coronary intervention with Resolute Onyx™ stent.
2. To evaluate the long-term efficacy and safety of coronary stenting with the Resolute Onyx™ stent.
3. To compare the long-term efficacy and safety of coronary stenting between the Resolute Onyx™ stent and other contemporary drug-eluting stents which had established their own registry.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RESOLUTE ONYX China Single Arm Study
NCT03471845
RESOLUTE ONYX China RCT Study
NCT03466151
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
NCT02419521
Registry of RESOLUTE-ONYX™ Zotarolimus-eluting Stent Utilization in Percutaneous Small Vessel Coronary Interventionism.
NCT04785846
Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)
NCT01605721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Stent thrombosis-24 hours(acute), 30 days(subacute), 1 year(late), every 1 year till 3 years(very-late) after index PCI (percutaneous coronary intervention),
2. Target vessel failure
3. Composite rate of cardiac death and any MI, 3 years
4. Composite rate of all death and any MI
5. Composite rate of all death, any MI, and any repeat revascularization
6. Compliance and therapy interruptions with prescribed adjunctive antiplatelet therapy
7. Clinical device and procedural success
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Onyx
The patients who received PCI with Resolute Onyx stent(s)
Resolute Onyx
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resolute Onyx
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who received PCI with Resolute Onyx™ stent(s)
Exclusion Criteria
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyo-Soo Kim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyo-soo Kim, MD, PhD
Role: STUDY_CHAIR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kosin University Gospel Hospital
Busan, , South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, , South Korea
Myongji Hospital
Goyang, , South Korea
Gwangju Christian Hospital
Gwangju, , South Korea
Kwangju Veterans Hospital
Gwangju, , South Korea
Chungbuk National University Hospital
Jeonju, , South Korea
Presbyterian Medical Center
Jeonju, , South Korea
Gyeongsang National University Hospital
Jinju, , South Korea
Pusan National University Hospital
Pusan, , South Korea
Seoul National University Bundang Hospital
Seongnam, , South Korea
Gangbuk Samsung Hospital
Seoul, , South Korea
Gangnam Severance Hospital
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Soonchunhyang University Hospital
Seoul, , South Korea
St. Vincent's Hospital
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jeong Ho Heo
Role: primary
Deok-Kyu Cho
Role: primary
Seung Uk Lee
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HOST-ONYX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.